<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>The First Blag Post</title>
    <link rel="stylesheet" href="../css/main.css">
    <link rel="stylesheet" href="../css/blag.css">
</head>
<body>
    <nav class="navbar">
        <ul>
            <li><a href="../index.html">Home</a></li>
            <li><a href="../blag.html">Blog</a></li>
            <li><a href="../about.html">About</a></li>
            <li><a href="../things.html">Things</a></li>
        </ul>
    </nav>

    <main>
        <article class="blog-post">
            <header>
                <h1>mRNA Vaccines</h1>
                <p class="author">By Aaron Chen</p>
                <time datetime="2025-08-30" class="date">August 30, 2025</time>
            </header>
            
            <p>In August 2025, NIH Director Jay Bhattacharya announced a pivot away from mRNA vaccine development, citing public distrust and scientific uncertainty. Bhattacharya argues that while mRNA technology showed promise, its deployment during the pandemic failed to build sustained public trust, which is a critical barrier for future vaccine use, especially in emergencies. Just weeks after, the U.S. Department of Health and Human Services (HHS), under Secretary Robert F. Kennedy Jr., announced the termination of multiple mRNA vaccine development projects, including nearly $500 million in funding tied to the Biomedical Advanced Research and Development Authority (BARDA), citing concerns about long-term safety and public trust. Beyond mRNA funding, thousands of research grants were terminated in early 2025, due to topics disfavoured by the Trump administration, notably, millions of dollars in grants related to DEI initiatives. These decisions have sparked debate, not just about mRNA technology, but about how we communicate science, build trust, and prepare for future pandemics.</p>
            
            <p>The claim that mRNA vaccines are ineffective against viruses that infect the upper respiratory tract has some truth to it, but it is still a broad statement. mRNA vaccines have been shown to reduce transmission, especially in the short term, and prevent severe illness and death, which is the primary goal of vaccination. The idea that a single mutation 'renders it ineffective' is not entirely accurate: vaccines still offer protection against variants, even if less robustly. Additionally, the nature of mRNA vaccines allow us to quickly develop newer vaccines when a strain has mutated. That's why mRNA vaccines remain powerful tools even against evolving viruses. mRNA vaccines were instrumental during the 2020 pandemic, significantly lowering hospitalization and death rates. A 2020 study in the New England Journal of Medicine found that the incidence of symptomatic COVID-19 was dramatically higher in placebo recipients than in those who received the first dose: a clear demonstration of the platform's real-world effectiveness.</p>
            
            <p>Dr. Bhattacharya rightly identifies public distrust as a legitimate challenge. It's understandable that many remain cautious, especially given the profound disruptions that followed years of pandemic response, like health impacts and social isolation. But framing distrust as a reason to abandon a promising technology oversimplifies a complex issue. As Bhattacharya himself stated: "Science isn't propaganda. It's humility. And when public health officials stopped communicating with humility, we lost much of the public, an absolute necessity for any vaccine platform." The solution isn't to cut investment in a promising technology, but to invest more in transparent, community-centered science communication. Completely abandoning mRNA vaccines is not the best way to increase transparency, humility, and community-led communication. Trust isn't built through withdrawal, but with inclusion, and sustained dialogue, like Dr. Bhattacharya says. Abandoning mRNA research entirely undermines our capacity to respond quickly to future variants or emerging pathogens. The dangerous risk here is premature disinvestment in technologies that could save millions of lives in humanity's next crisis.</p>
            
            <h2>References</h2>
            <ol>
                <li><a href="https://www.nature.com/articles/d41586-025-02721-5">Nature Article: US Supreme Court allows NIH to cut $2 billion in research grants</a></li>
                <li><a href="https://www.nytimes.com/2025/08/05/health/rfk-jr-vaccine-funding.html?searchResultPosition=6">NY Times: Kennedy Cancels Nearly $500 Million in mRNA Vaccine Contracts</a></li>
                <li><a href="https://www.washingtonpost.com/opinions/2025/08/12/nih-mrna-vaccines-jay-bhattacharya/">Washington Post Opinion: Jay Bhattacharya on Why the NIH is pivoting away from mRNA vaccines</a></li>
                <li><a href="https://www.nejm.org/doi/full/10.1056/nejmoa2034577">NEJM Study: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine</a></li>
                <li><a href="https://www.nature.com/articles/s41467-024-45348-2">Nature Study: An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission</a></li>
            </ol>
        </article>
    </main>
</body>
</html>
